ABSQUANT

Welcome to the Brand page for “ABSQUANT”, which is offered here for Development of cancer immunotherapy treatment options based on medical evaluation of individual patients;research and development in the pharmaceutical and biotechnology fields; medical research; development of pharmaceutical preparations and medicines; scientific research;.

Its status is currently believed to be active. Its class is unavailable. “ABSQUANT” is believed to be currently owned by “immatics biotechnologies GmbH”.


Owner:
IMMATICS BIOTECHNOLOGIES GMBH
Owner Details
Description:
Development of cancer immunotherapy treatment options based on medical evaluation of individual patients;Research and development in the pharmaceutical and biotechnology fields; Medical research; Development of pharmaceutical preparations and medicines; Scientific research;
Categories: DEVELOPMENT CANCER IMMUNOTHERAPY TREATMENT